ArticleInternal medicine (Tokyo, Japan)2018
Hepatic Pseudolymphoma with an Occult Hepatitis B Virus Infection.
Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 16 citations in OpenAlex.
- Hepatic reactive lymphoid hyperplasia diagnosed through post-ablation liver tumor biopsy.Clinical journal of gastroenterology · 2025Article
- MR imaging findings of hepatic pseudolymphoma: common and rare features.Abdominal radiology (New York) · 2025Article
- Intrahepatic Lymphoid Follicles Comprising T and B Cells Mimic Hepatocellular Carcinoma in a Hepatitis B Patient.International journal of molecular sciences · 2025Article
- A case of hepatic reactive lymphoid hyperplasia: the review of 23 cases from the literatures.Clinical journal of gastroenterology · 2023Article
- Lymphoid hyperplasia with a polyp form of the gallbladder macroscopically mimicking carcinoma.Clinical journal of gastroenterology · 2022Article
- Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: A case report.World journal of clinical cases · 2020Article
- A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.Surgical case reports · 2020Article
- Reactive lymphoid hyperplasia of the liver: A case report.Medicine · 2019Article
- Potential value of apparent diffusion coefficient in the evaluation of hepatic pseudolymphoma.Quantitative imaging in medicine and surgery · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 49-year-old woman who was asymptomatic was found to have a small liver tumor on abdominal ultrasonography (US) at her annual health checkup. US revealed a hypoechoic, solid, mass measuring 17-mm in size in segment 6. The tumor markers associated with liver malignancy were negative. An infectious disease screen was negative for hepatitis B surface antigen, but positive for antibody to hepatitis B core antigen. Imaging studies using computed tomography (CT), magnetic resonance imaging (MRI), and CT angiography suggested a malignant liver tumor, such as hepatocellular carcinoma. Partial hepatic resection of the posterior segment was performed. The pathological diagnosis was pseudolymphoma of the liver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.